Zydus Lifesciences gets Rs 1.61 crore GST demand for FY 2017-18
Ahmedabad: Zydus Lifesciences Limited has received a Demand Order-In-Original ("O-I-O") of Rs 1.61 crore from the Assistant Commissioner, Division Dehradun, Sector-7, Uttarakhand for the financial year 2017-18 on the issue pertaining to ITC carried forward through TRAN-1.
The demand is raised against alleged ITC carried forward through TRAN-1 during the financial year 2017-18. The Company has not received any notice or show cause notice on which demand has been issued.
"The Company intends to challenge the order by filing an appeal against the said order. There is no material financial impact on the Company," Zydus informed in a BSE filing.
Medical Dialogues team has recently reported that Drug major Cipla Limited has disclosed that the Office of the Principal Commissioner of Central Goods & Services Tax (GST) and Central Excise in Lucknow has imposed a penalty of Rs 53,09,449 on the company.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.